FIELD: medicine. SUBSTANCE: method involves per os administering WESSEL DU F (Sulodexid) at a dose of one capsule every day before going to bed during 2-12 months. EFFECT: enhanced effectiveness of treatment; improved venous blood discharge through hepatic vein; reduced manifestations of cytolytic and mesenchymal inflammation syndromes. 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF HEPATIC DISEASE | 2001 |
|
RU2219930C2 |
METHOD FOR TREATMENT OF LIVER DISEASE | 2004 |
|
RU2286773C2 |
METHOD FOR APPLYING PHYSIOTHERAPEUTIC LIVER TREATMENT | 2002 |
|
RU2232609C2 |
METHOD FOR TREATING CHRONIC LIVER DISEASES AGGRAVATED BY HBsAg CARRIAGE WITH LOW INTENSITY HELIUM-NEON LASER IRRADIATION OF BLOOD | 1995 |
|
RU2144836C1 |
METHOD FOR TREATING THE CASES OF CHRONIC LIVER DISEASES WITH HEPATIC INSUFFICIENCY MANIFESTATIONS BY MEANS OF PLASMAPHERESIS | 1995 |
|
RU2146948C1 |
METHOD FOR TREATING THE PATIENTS SUFFERING FROM HEMOCHROMATOSIS BY APPLYING CYTOPHERESIS | 1996 |
|
RU2146543C1 |
METHOD FOR TREATING THE CHRONIC VIRAL HEPATITIS C PATIENTS HAVING HEPATIC HEMOSIDEROSIS | 1999 |
|
RU2180599C2 |
AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS OF AN INFECTIOUS ETIOLOGY | 1996 |
|
RU2122418C1 |
METHOD FOR EVALUATING HEPATIC HEMODYNAMICS | 2002 |
|
RU2214158C1 |
METHOD FOR TREATING THE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AT APPLYING THE CRYOHEPARINOPRECIPITATION | 2000 |
|
RU2188012C2 |
Authors
Dates
2002-03-10—Published
2000-11-13—Filed